Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Akanksha Sharma, PHD Mechanisms of liver failure Department of Veteran Affairs VA/IPA_Sharma 07/02/2019 - 12/31/2019 $49,183
Akanksha Sharma, PHD Mechanisms of liver failure Department of Veteran Affairs VA/IPA 03/17/2020 - 03/16/2021 $59,521
Akihiro Asai, MD-PHD Modeling patient-specific genetic cholestasis with induced human hepatocytes Amer Assoc for the Study of Liver Dis AASLD- 2018 AASLD 07/01/2019 - 10/31/2020 $100,000
Alexander Miethke, MD Control of hepatic T cell responses in biliary atresia National Institutes of Health (NIH) R01DK095001 07/01/2019 - 04/30/2021 $825,726
Alexander Miethke, MD A Multicenter Extension Study to Evaluate the Long-Term Safety and Durability of the Therapeutic Effect of LUM001, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Pediatric Subjects with Alagille Syndrome (“IMAGINE-II”) University of Michigan (National Institutes of Health) SUBK00012525 12/01/2019 - 05/31/2020 $79,500
Alok K Verma, PHD Mechanisms of liver failure Department of Veteran Affairs VA,IPA 03/10/2020 - 03/09/2021 $50,377
Chunyue Yin, PHD Molecular targets in cholestasis caused by bile salt export pump deficiency National Institutes of Health (NIH) R01DK117266 08/01/2019 - 07/31/2020 $362,414
James E Heubi, MD Sterol and Isoprenoid Diseases Rare Diseases Consortium University of Nebraska Medical Center (National Institutes of Health) 34-5321-2003-010 09/01/2018 - 08/31/2019 $8,638
Jorge A Bezerra, MD Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Disease National Institutes of Health (NIH) P30DK078392 06/01/2019 - 05/31/2021 $2,349,225
Jorge A Bezerra, MD Immunologic Dysfunction in Biliary Atresia National Institutes of Health (NIH) R01DK064008 02/01/2020 - 01/31/2021 $446,970
Jorge A Bezerra, MD Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia National Institutes of Health (NIH) 2R01DK083781 09/17/2019 - 06/30/2020 $526,622
Jorge A Bezerra, MD Clinical Center for Cholestatic Liver Disease in Children National Institutes of Health (NIH) 2U01DK062497 09/19/2019 - 05/31/2021 $1,243,768
Joseph Palermo, MD-PHD Longitudinal Study of Cystic Fibrosis Liver Disease The Children's Hospital of Denver (Cystic Fibrosis Fdn Therapeutics, Inc) NARKEW07AO 01/01/2019 - 12/31/2019 $109,632
Kelli L VanDussen, PHD Defining the basis of epithelial defects in Crohn's disease patients National Institutes of Health (NIH) K01DK109081 02/01/2020 - 01/31/2021 $144,838
Lee A Denson, MD Development of a Human Intestinal Organoid Model for Stricturing Ileal Crohn's Disease Crohn's & Colitis Foundation of America 659172 01/01/2020 - 12/31/2020 $115,830
Lee A Denson, MD Causes and consequences of neutrophil dysfunction in early onset Crohn’s disease Emory University (National Institutes of Health) A229615 03/01/2019 - 02/29/2020 $79,500
Lee A Denson, MD A multidisciplinary human study on the genetic, environmental and microbial interactions that cause IBD Mount Sinai Hospital (Icahn School of Medicine at Mount Sinai) Mt. Sinai_GEM_amend 03/31/2019 - 03/30/2020 $1,750
Lee A Denson, MD Pediatric Gastroenterology and Nutrition Training Grant National Institutes of Health (NIH) T32DK007727 07/01/2019 - 06/30/2020 $478,248
Lee A Denson, MD Dosing and Pilot Efficacy of 2'-Fucosyllactose in Inflammatory Bowel Disease National Institutes of Health (NIH) R01HD094862 04/01/2020 - 03/31/2021 $666,974
Maisam Abu-El-Haija, MD Predicting Severity and Improving the Outcomes of Pediatric Pancreatitis National Institutes of Health (NIH) K23DK118190 06/01/2020 - 05/31/2021 $189,292
Maisam Abu-El-Haija, MD Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC) "Study" University of Iowa (National Institutes of Health) W001038585 09/01/2018 - 08/31/2020 $22,000
Maisam Abu-El-Haija, MD A randomized trial of a web-based non-pharmacological pain intervention for pediatric chronic pancreatitis University of Iowa (National Institutes of Health) S00779-01 09/15/2018 - 05/31/2020 $1,950
Michael Rosen, MD-MS The role of SPRY2 in the colonic epithelial response to inflammation Children's Hospital Los Angeles (National Institutes of Health) RGF011923-A 08/20/2019 - 05/31/2020 $31,592
Michael Rosen, MD-MS Type 2 cytokines and innate lymphoid cells in pediatric ulcerative colitis National Institutes of Health (NIH) R01DK117119 06/01/2019 - 05/31/2021 $1,033,977
Michael Rosen, MD-MS Systems biology of microbe-mediated glucosinolate bioconversion in inflammatory bowel disease University of Virginia (National Institute for Health Research) R01AT010253 09/01/2018 - 08/31/2020 $80,181
Phillip P. Minar, MD Pharmacokinetic Evaluation to Optimize Infliximab Monotherapy with Personalized Pharmacodynamic Biomarkers National Institutes of Health (NIH) R03DK118314 09/01/2019 - 08/31/2020 $119,250
Stacey Huppert, PHD Building a functional biliary system from hepatocytes National Institutes of Health (NIH) R01 DK107553 08/01/2019 - 07/31/2020 $434,900
Stacey Huppert, PHD Molecular regulation of hepatic cell differentiation and maturation National Institutes of Health (NIH) R01DK120765 09/23/2019 - 07/31/2020 $402,806
Stavra A Xanthakos, MD Non Alcoholic Steatohepatitis Clinical Research Network Cleveland Clin Lerner Col of Med of CWRU (National Institutes of Health) 1324-SUB 07/01/2019 - 06/30/2020 $162,070
Takanori Takebe, MD Novel Human Liver Organoid Transplantation Against Pediatric Liver Disease Dr. Ralph & Marian Falk Med Res Trust Aw FMR_Takebe 11/30/2019 - 11/29/2020 $300,000
Takanori Takebe, MD Clinical Translation Of Organ Bud Transplant Therapy The New York Stem Cell Foundation NYSCF-R-I38 01/01/2019 - 12/31/2019 $300,000
Xiaonan Han, PHD Regulation of Niche Cell Differentiation to Sustain Intestinal Stem Cell Regeneration Against Gut Inflammation National Institutes of Health (NIH) R01DK123299 01/01/2020 - 12/31/2020 $357,750
Current Year Direct $11,134,484

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Alexander Miethke, MD Mirum Pharmaceuticals, Inc. $31,826.00
Conrad R Cole, MD Fresenius kabi Deutschland GmbH $82,391.00
James E Heubi, MD Friesland Campina Research $647,407.00
Stavra A Xanthakos, MD Axcella Health Inc. $67,299.00
Vincent A Mukkada, MD Shire Human Genetic Therapies $29,570.00
Total Annual Industry Award Dollars $858,493.00